Despite a wide variety of available pharmacotherapies, chronic pain remains a poorly controlled condition. Major barriers in optimal management include inadequate screening and assessment, lack of understanding of its complicated pathophysiology, and subsequent underuse of neuromodulatory analgesics to target specific underlying pathogenesis. Thus, there is a critical need to discuss how to overcome these knowledge and performance barriers and to provide clinicians with access to experts who can highlight and prioritize emerging data. This Education Station™ activity will include an overview of chronic pain and 3 topics using clinical case scenarios in a discussion-based format.
This activity is designed for internal medicine clinicians and other healthcare professionals interested in the management of chronic pain.
At the conclusion of this activity, users will be able to:
- Perform appropriate screening and assessment when managing patients with chronic pain
- Select mechanism-specific treatments based on underlying chronic pain pathophysiology
- Incorporate neuromodulatory analgesics into a multimodal chronic pain management regimen based on efficacy and safety data from clinical trials
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Postgraduate Institute for Medicine and ACCELMED. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health and Family Medicine
University of Florida
Daniel J. Clauw, MD
Professor of Anesthesiology and Medicine (Rheumatology)
Director, Chronic Pain and Fatigue Research Center
University of Michigan
Ann Arbor, Michigan
Perry G. Fine, MD
Professor of Anesthesiology
Pain Research Center
School of Medicine
University of Utah
Salt Lake City, Utah
The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Louis Kuritzky, MD:
Consultant Fees: Lilly USA, LLC
Daniel J. Clauw, MD:
Consultant Fees: Cypress Bioscience, Inc.; Forest Laboratories, Inc; Jazz Pharmaceuticals, Inc.; Lilly USA, LLC; Merck & Co., Inc.; Pfizer Inc.; Pierre Fabre Pharmaceuticals Inc.; UCB S.A.
Contracted Research: Forest Laboratories, Inc; Merck & Co., Inc.
Perry G. Fine, MD:
Consultant Fees: Ameritox Medication Monitoring Solutions; Archimedes Pharma Ltd; Cephalon, Inc.; Johnson & Johnson Services, Inc.; Nuvo Research Inc.; Purdue Pharma L.P.
Speakers’ Bureaus: PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Ownership Interest: Asante Communications, LLC
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The following PIM staff serve as clinical content reviewers and/or participate in planning CME/CE activities in a manner that may affect content: Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, CCMEP; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples; MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME/CE activity of any amount during the past 12 months.
The following ACCELMED planners and managers, Jason LeDune, MS, and Jason Xu, MD, PhD, hereby state that they or their spouse/life partner have no relationships with commercial interests, and the spouse of Janardhan Sampath, PhD, is an employee of Bristol-Myers Squibb Company.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. PIM, ACCELMED, and Lilly USA, LLC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ACCELMED, and Lilly USA, LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly sponsored by the Postgraduate Institute for Medicine and ACCELMED.
If you have any questions relating to the accreditation for this activity, please contact:
Postgraduate Institute for Medicine
This activity is supported by an educational grant from Lilly USA, LLC.
Method of Participation
There are no fees for participating and receiving CME credit for this activity. During the period June 26, 2012 through June 26, 2013, participants must read the learning objectives and faculty disclosures and study the educational activity.
PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. Upon successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.
If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.